SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-016872
Filing Date
2022-03-07
Accepted
2022-03-07 19:58:01
Documents
1
Period of Report
2022-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10391
  Complete submission text file 0001209191-22-016872.txt   11770
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CARIBOU BIOSCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Kanner Steven (Reporting) CIK: 0001871131 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 22719988